Clinical Trial Update: Phase I Trial of Tanibirumab in Advanced or Metastatic Cancer [Phase 1]

View source ↗

Summary

Phase I study of Tanibirumab in advanced or metastatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Tanibirumab (Tanibirumab)

Snippet

Sponsor: PharmAbcine | Conditions: Advanced Cancer, Metastatic Cancer | Phase 1 | Status: COMPLETED